{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T04:24:35Z","timestamp":1792556675228,"version":"4.5.0"},"reference-count":44,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2002,6,28]],"date-time":"2002-06-28T00:00:00Z","timestamp":1025222400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer"],"published-print":{"date-parts":[[2002,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>BACKGROUND<\/jats:title><jats:p>In the past 20 years, a dramatic improvement in the prognosis of patients with hepatoblastoma (HB) has been achieved by combining surgery with chemotherapy in several national and international trials. A worldwide, unsolved problem remains the treatment of patients with advanced or metastatic HB.<\/jats:p><\/jats:sec><jats:sec><jats:title>METHODS<\/jats:title><jats:p>The German Cooperative Pediatric Liver Tumor Study HB 94 was a prospective, multicenter, single\u2010arm study. The study ran from January 1994 to December 1998. The protocol assessed the efficiency of chemotherapy consisting of cisplatin, ifosfamide, and doxorubicin (CDDP\/IFO\/DOXO) and\/or etoposide and carboplatin (VP16\/CARBO). The prognostic significance of the surgical strategy, pretreatment factors, and tumor characteristics for disease free survival (DFS) were analyzed.<\/jats:p><\/jats:sec><jats:sec><jats:title>RESULTS<\/jats:title><jats:p>Sixty\u2010nine children with HB were treated in the HB 94 study. The median follow\u2010up of survivors was 58 months (range, 32\u201393 months). Fifty\u2010three of 69 patients (77%) remained alive, and 16 of 69 patients (23%) died. Long\u2010term DFS was as follows: 26 of 27 patients had Stage I HB, 3 of 3 patients had Stage II HB, 19 of 25 patients had Stage III HB, and 5 of 14 patients had Stage IV. A complete resection of the primary tumor was achieved in 54 of 63 patients (86%). Six children (8%) had no surgical treatment. Twenty\u2010two tumors were resected primarily, and 41 children underwent surgery after initial chemotherapy. Two children underwent liver transplantation. There was no perioperative death. Forty\u2010eight children received primary chemotherapy with CDDP\/IFO\/DOXO. Forty\u2010one of 48 children achieved partial remission after CDDP\/IFO\/DOXO. Eighteen children with advanced or recurrent HB underwent VP16\/CARBO chemotherapy, with a response achieved by 12 children. The relevant pretreatment prognostic factors were growth pattern of the liver tumor (<jats:italic>P<\/jats:italic> = 0.0135), vascular tumor invasion (<jats:italic>P<\/jats:italic> = 0.0039), occurrence of distant metastases (<jats:italic>P<\/jats:italic> = 0.0001), initial \u03b1\u2010fetoprotein level (<jats:italic>P<\/jats:italic> = 0.0034), and surgical radicality (<jats:italic>P<\/jats:italic> &lt; 0.0001).<\/jats:p><\/jats:sec><jats:sec><jats:title>CONCLUSIONS<\/jats:title><jats:p>The current results underline the necessity of preoperative chemotherapy in all children with HB. Complete tumor resection is one of the main prognostic factors. Cancer 2002;95:172\u201382. \u00a9 2002 American Cancer Society.<\/jats:p><jats:p>DOI 10.1002\/cncr.10632<\/jats:p><\/jats:sec>","DOI":"10.1002\/cncr.10632","type":"journal-article","created":{"date-parts":[[2002,8,25]],"date-time":"2002-08-25T19:33:49Z","timestamp":1030304029000},"page":"172-182","source":"Crossref","is-referenced-by-count":219,"title":["Pretreatment prognostic factors and treatment results in children with hepatoblastoma"],"prefix":"10.1002","volume":"95","author":[{"given":"J\u00f6rg","family":"Fuchs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Rydzynski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dietrich","family":"Von Schweinitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Udo","family":"Bode","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hartmut","family":"Hecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Weinel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dietrich","family":"B\u00fcrger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieter","family":"Harms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudolf","family":"Erttmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Oldhafer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hermann","family":"Mildenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the Study Committee of the Cooperative Pediatric Liver Tumor Study Hb 94 for the German Society for the Pediatric Oncology and Hematology","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2002,6,28]]},"reference":[{"key":"e_1_2_6_2_2","first-page":"636","article-title":"Primary hepatic tumors in childhood","volume":"5","author":"Ishak KG","year":"1976","journal-title":"Progr Liver Dis."},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-911X(199803)30:3<141::AID-MPO1>3.0.CO;2-H"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(1967)20:3<396::AID-CNCR2820200308>3.0.CO;2-O"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2000.18.14.2665"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1053\/spsu.2001.24887"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0046-8177(83)80005-7"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-3468(92)90564-N"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-3468(95)90762-9"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(97)00095-6"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2008-1066073"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1053\/jpsu.2001.22953"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4615-5767-8_7"},{"key":"e_1_2_6_14_2","first-page":"38","article-title":"Hepatic tumors in children","volume":"6","author":"Newman KD","year":"1997","journal-title":"Semin Pediatr Surg."},{"key":"e_1_2_6_15_2","first-page":"3127","article-title":"Altered expression of resistance associated genes in hepatoblastoma xenografts incorporated into mice following treatment with Adriamycin or cisplatin","volume":"18","author":"Bader P","year":"1998","journal-title":"Anticancer Res."},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19981201)83:11<2400::AID-CNCR21>3.0.CO;2-6"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-911X(199903)32:3<209::AID-MPO8>3.0.CO;2-0"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.1950230895"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(00)00074-5"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1053\/spsu.2000.18844"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1993.11.1.96"},{"key":"e_1_2_6_22_2","first-page":"591","article-title":"Preoperative chemotherapy in hepatoblastoma","volume":"110","author":"Filler RM","year":"1992","journal-title":"Surgery."},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3468(96)90147-5"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2008-1043805"},{"key":"e_1_2_6_25_2","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/milmed\/158.1.51","article-title":"Hepatoblastoma: a rare pediatric neoplasm","volume":"158","author":"Brown BF","year":"1993","journal-title":"Mil Med."},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(00)00138-6"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1007\/s001040051121"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1053\/jpsu.2001.20055"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1053\/jpsu.2000.9300"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0041-1345(00)02827-X"},{"key":"e_1_2_6_31_2","doi-asserted-by":"crossref","first-page":"33S","DOI":"10.1002\/hep.1840200710","article-title":"Indications for liver transplantation in hepatobilliary malignancy","volume":"20","author":"Pichlmayr R","year":"1994","journal-title":"Hepatology."},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(00)44469-0"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19930201)71:3<859::AID-CNCR2820710333>3.0.CO;2-T"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1007\/s003830050403"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-198212000-00001"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1002\/mpo.1089"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(20001015)89:8<1845::AID-CNCR27>3.0.CO;2-D"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00299776"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3468(96)90242-0"},{"key":"e_1_2_6_40_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2000.18.22.3819"},{"key":"e_1_2_6_41_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19971219)74:6<593::AID-IJC6>3.0.CO;2-P"},{"key":"e_1_2_6_42_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1997.15.3.1190"},{"key":"e_1_2_6_43_2","doi-asserted-by":"publisher","DOI":"10.3109\/15513819209023293"},{"key":"e_1_2_6_44_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19890901)64:5<1082::AID-CNCR2820640520>3.0.CO;2-G"},{"key":"e_1_2_6_45_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-199312000-00008"}],"container-title":["Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fcncr.10632","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cncr.10632","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T21:38:24Z","timestamp":1760305104000},"score":1,"resource":{"primary":{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/10.1002\/cncr.10632"}},"subtitle":["A Report from the German Cooperative Pediatric Liver Tumor Study HB 94"],"short-title":[],"issued":{"date-parts":[[2002,6,28]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002,7]]}},"alternative-id":["10.1002\/cncr.10632"],"URL":"https:\/\/doi.org\/10.1002\/cncr.10632","archive":["Portico"],"relation":{},"ISSN":["0008-543X","1097-0142"],"issn-type":[{"value":"0008-543X","type":"print"},{"value":"1097-0142","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,6,28]]}}}